Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-26T18:58:40.014Z Has data issue: false hasContentIssue false

Chapter 19 - Section summary and perspectives: Neurodevelopmental disorders and regulation of epigenetic changes

Published online by Cambridge University Press:  05 July 2012

By
James E. Barrett  and
Joseph T. Coyle
Edited by
James E. Barrett ,
Joseph T. Coyle  and
Michael Williams
James E. Barrett
Affiliation:
Drexel University, Philadelphia
Joseph T. Coyle
Affiliation:
Harvard University School of Medicine, Massachusetts
Michael Williams
Affiliation:
Drexel University, Philadelphia
Get access

Summary

There is increasing recognition that many central nervous system (CNS) disorders, including those involving neurodevelopment, may represent disorders of epigenetic regulation. Recently, a new level of epigenetic regulation by small noncoding RNAs, termed microRNAs (miRNAs), has been discovered that regulates gene expression at different levels. The field of epigenetics may be an important approach to breaking the bottleneck in the understanding and treatment of neuropsychiatric disorders. Unlike the DNA sequence, epigenetic changes are reversible, providing opportunities to affect those changes that occur though dysregulation and opening up new opportunities for the treatment of CNS disorders. As such, the widespread importance of epigenetic modification to the neurosciences may herald a new era both in our understanding of the pathophysiology of these disorders and in the ability to develop new therapeutics to treat them. These studies could be of critical importance for the treatment and prevention of autism and other genetic disorders.

Keywords

animal modelbiomarkerdopamine agonistsnondopaminergic agentParkinson's diseasemotor symptomsdopamine therapy
Type
Chapter
Information
Translational Neuroscience
Applications in Psychiatry, Neurology, and Neurodevelopmental Disorders
 , pp. 334 - 338
Publisher: Cambridge University Press
Print publication year: 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×